Consistent with our previous studies [20], the activation of caspase 3/7 was further increased in BITC-treated cells pretreated with autophagy inhibitors, including 3-MA and Baf A1, in prostate cancer cells (Figure 5E and 5F). Here, CASP3 is linked to prostate carcinoma.